| Primary |
| Rosacea |
57.0% |
| Hypertension |
6.1% |
| Vaginitis Bacterial |
5.3% |
| Therapeutic Skin Care Topical |
4.4% |
| Drug Use For Unknown Indication |
3.5% |
| Multiple Allergies |
2.6% |
| Acne |
1.8% |
| Asthma |
1.8% |
| Atrial Fibrillation |
1.8% |
| Diabetes Mellitus |
1.8% |
| Gastrooesophageal Reflux Disease |
1.8% |
| Hypercholesterolaemia |
1.8% |
| Pain In Extremity |
1.8% |
| Prophylaxis |
1.8% |
| Sleep Disorder |
1.8% |
| Trigeminal Neuralgia |
1.8% |
| Atonic Urinary Bladder |
0.9% |
| Cardiac Disorder |
0.9% |
| Convulsion |
0.9% |
| Diarrhoea |
0.9% |
|
| Paraesthesia |
10.4% |
| Neuropathy Peripheral |
8.3% |
| Skin Irritation |
8.3% |
| Rash |
6.3% |
| Skin Disorder |
6.3% |
| Swollen Tongue |
6.3% |
| Vomiting |
6.3% |
| Drug Exposure During Pregnancy |
4.2% |
| Drug Ineffective |
4.2% |
| Erythema |
4.2% |
| Headache |
4.2% |
| Lymphoma |
4.2% |
| Non-hodgkin's Lymphoma Unspecified Histology Indolent |
4.2% |
| Pain In Extremity |
4.2% |
| Palpitations |
4.2% |
| Pruritus |
4.2% |
| White Blood Cell Count Decreased |
4.2% |
| Benign Intracranial Hypertension |
2.1% |
| Breast Cancer Female |
2.1% |
| Condition Aggravated |
2.1% |
|
| Secondary |
| Rosacea |
43.9% |
| Foetal Exposure During Pregnancy |
12.3% |
| Diabetes Mellitus |
7.0% |
| Ventricular Tachycardia |
5.3% |
| Asthma |
3.5% |
| Hypercholesterolaemia |
3.5% |
| Multiple Allergies |
3.5% |
| Product Used For Unknown Indication |
3.5% |
| Anxiety |
2.6% |
| Pain |
2.6% |
| Bacterial Vaginosis |
1.8% |
| Drug Use For Unknown Indication |
1.8% |
| Hypertension |
1.8% |
| Rash |
1.8% |
| Attention Deficit/hyperactivity Disorder |
0.9% |
| Cheilitis |
0.9% |
| Crohn's Disease |
0.9% |
| Cystitis Interstitial |
0.9% |
| Hormone Replacement Therapy |
0.9% |
| Hypersensitivity |
0.9% |
|
| Skin Irritation |
12.9% |
| Drug Ineffective |
9.7% |
| Abdominal Pain |
6.5% |
| Condition Aggravated |
6.5% |
| Diverticulitis |
6.5% |
| Drug Hypersensitivity |
6.5% |
| Paraesthesia |
6.5% |
| Skin Burning Sensation |
6.5% |
| Abasia |
3.2% |
| Abdominal Discomfort |
3.2% |
| Incorrect Drug Administration Duration |
3.2% |
| International Normalised Ratio Increased |
3.2% |
| Nausea |
3.2% |
| Off Label Use |
3.2% |
| Otitis Media Chronic |
3.2% |
| Pregnancy Test Positive |
3.2% |
| Product Packaging Quantity Issue |
3.2% |
| Pruritus |
3.2% |
| Similar Reaction On Previous Exposure To Drug |
3.2% |
| Skin Exfoliation |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.1% |
| Drug Use For Unknown Indication |
14.4% |
| Rosacea |
7.2% |
| Depression |
4.6% |
| Hypertension |
4.6% |
| Acne |
4.1% |
| Pain |
3.6% |
| Rheumatoid Arthritis |
3.4% |
| Asthma |
3.4% |
| Gastrooesophageal Reflux Disease |
3.1% |
| Contraception |
3.0% |
| Supplementation Therapy |
2.7% |
| Anxiety |
2.4% |
| Crohn's Disease |
2.4% |
| Insomnia |
2.3% |
| Headache |
2.1% |
| Prophylaxis |
2.1% |
| Multiple Sclerosis |
1.9% |
| Hypersensitivity |
1.8% |
| Blood Cholesterol Increased |
1.6% |
|
| Pain |
12.3% |
| Vomiting |
9.0% |
| Pulmonary Embolism |
7.1% |
| Stress |
6.5% |
| Upper Respiratory Tract Infection |
5.8% |
| Walking Aid User |
5.8% |
| Weight Decreased |
5.2% |
| Weight Increased |
4.5% |
| Cellulitis |
3.9% |
| Diarrhoea |
3.9% |
| Flushing |
3.9% |
| Myalgia |
3.9% |
| Nausea |
3.9% |
| Oedema Peripheral |
3.9% |
| Pneumonia |
3.9% |
| Rash |
3.9% |
| Breast Cancer |
3.2% |
| Cholecystitis Chronic |
3.2% |
| Death |
3.2% |
| Electrocardiogram Qt Corrected Interval Prolonged |
3.2% |
|
